← Browse by Condition
Medical Condition

aortic valve disease

Total Trials
8
Recruiting Now
8
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for aortic valve disease sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — aortic valve disease Clinical Trials

How many clinical trials are currently recruiting for aortic valve disease?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for aortic valve disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for aortic valve disease?
aortic valve disease research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a aortic valve disease clinical trial?
Eligibility criteria for aortic valve disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Nanjing First Hospital, Nanjing Medical University 1 trial
Rigshospitalet, Denmark 1 trial
Edwards Lifesciences 1 trial
National and Kapodistrian University of Athens 1 trial
Université Libre de Bruxelles 1 trial

Recruiting Clinical Trials

NCT04864145
Recruiting
Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation
Enrollment
210 pts
Location
China
Sponsor
Nanjing First Hospital, Nanjin...
View Trial →
NCT05635227
Recruiting
Dexamethasone, Olanzapine, Hemodynamics, and Ventilation in Cardiac Surgery
Enrollment
1,200 pts
Location
Denmark
Sponsor
Rigshospitalet, Denmark
View Trial →
NCT07120048
Recruiting
Real World Data Collection on the INSPIRIS RESILIA Aortic Valve
Enrollment
500 pts
Location
Germany
Sponsor
Edwards Lifesciences
View Trial →
NCT06189976
Recruiting
Rapid Atrial Pacing After TAVI to Predict Pacemaker Implantation
Enrollment
400 pts
Location
Belgium, Greece
Sponsor
National and Kapodistrian Univ...
View Trial →
NCT06286358
Recruiting
Aortopathy Relationship To Imagery and Kinocardiography Features (ARTIK)
Enrollment
180 pts
Location
Belgium
Sponsor
Université Libre de Bruxelles
View Trial →
NCT06126367
Recruiting
Assessment of Lipoprotein(a) and Endogenous Fibrinolysis in Atherosclerotic Cardiovascular Disease/Aortic Valve Disease
Enrollment
180 pts
Location
United Kingdom
Sponsor
East and North Hertfordshire N...
View Trial →
NCT07008911
Recruiting
CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation
Enrollment
200 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT07001007
Recruiting
SCAPIS 2 Cardio - Vibrometer Based Pulse Wave Analysis and CVD Risk Assessment
Enrollment
1,600 pts
Location
Sweden
Sponsor
HJN Sverige AB/Neko Health
View Trial →

Related Conditions

coronary artery disease (1) transcatheter aortic valve implantation (1) tavi (1) aortic aneurysm (1) atherosclerosis (1) aortic valve stenosis (1) coronary arterial disease cad (1) arterial stiffness (1) heart failure (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology